Ian M Silverman

9PUBLICATIONS
74CO-AUTHORS
Molecular targetsEvolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Ezra Y Rosen, Timothy A Yap, Elisa Fontana

|Jul 24, 2025
Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors.

Ian M Silverman, Joseph D Schonhoft, Benjamin Herzberg

|Apr 01, 2024
Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma.

Meredith S Pelster, Ian M Silverman, Joseph D Schonhoft

|Apr 01, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.

Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas

|Jun 05, 2023
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.

Timothy A Yap, Elisa Fontana, Elizabeth K Lee

|Sep 01, 2022
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko

Pageof 2